Sublingual Atropine Bioequivalence by Route of Administration (SABER)

Conditions: Atropine Bioequivalence Interventions: Drug: Atropine Sulfate Ophthalmic Solution USP, 1%; Drug: Atropine Sulfate Injection, USP 8 mg/20 mL (0.4 mg/mL) Sponsors: Biomedical Advanced Research and Development Authority; Rho Federal Systems Division, Inc.; Allucent Not yet recruiting

https://clinicaltrials.gov/study/NCT06366087

Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials

More News: Opthalmology | Research